{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T01:05:10Z","timestamp":1768871110172,"version":"3.49.0"},"reference-count":18,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cathet Cardio Intervent"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background:<\/jats:title><jats:p>As compared to treatment of aortic stenosis (AS), transcatheter aortic valve replacement (TAVR) using the commercially available valves to treat pure aortic regurgitation (PAR) has a lower device success rate and higher complication rates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>The study compared the acute results between TAVR using a novel noncoronary sinus pivot implantation (NCPI) method and that using the conventional method, aiming to explore a more optimized and effective operation method for TAVR in PAR.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>PAR patients who underwent TAVR with self\u2010expanding valves in our center from September 2021 to September 2023 were enrolled\u00a0were divided into the NCPI (group A, <jats:italic>N<\/jats:italic>\u2009=\u200916) and conventional method (group B, <jats:italic>N<\/jats:italic>\u2009=\u200939) groups. We analyzed the pre\u2010operative evaluation parameters\u00a0and procedural and postoperative data\u00a0of the two subgroups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The total patients\u2019 mean age was 71.2\u2009\u00b1\u20098.7 years and most were male (61.8%), with a mean Society of Thoracic Surgeons score of 3.4\u2009\u00b1\u20091.9%. The device success rate of groups A and B was 100% and 71.8%, respectively. In group B, 48.7% had major adverse cardiac events (MACE); 46.2% patients had permanent pacemaker implantation or valve in valve implantation. None had MACE in group A. The noncoronary sinus implantation depth in NCPI was \u22121.1\u2009+\u20091.0\u00a0and 4.2\u2009+\u20093.7\u2009mm in groups A and B (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>TAVR with a self\u2010expanding valve using the NCPI method had a higher procedure success rate and dramatically low complications than that using the conventional method in PAR patients.<\/jats:p><\/jats:sec>","DOI":"10.1002\/ccd.31064","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T13:08:45Z","timestamp":1714568925000},"page":"1093-1100","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparisons of noncoronary sinus pivot implantation (NCPI) and conventional method for transcatheter aortic valve replacement with self\u2010expanding valve in pure aortic regurgitation (PAR)"],"prefix":"10.1002","volume":"103","author":[{"given":"Lifan","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital Fudan University Minhang Meilong Shanghai China"},{"name":"National Clinical Research Center for Interventional Medicine Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shasha","family":"Chen","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Interventional Medicine Shanghai China"},{"name":"Department of Cardiology, Zhongshan Hospital Fudan University Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochun","family":"Zhang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Interventional Medicine Shanghai China"},{"name":"Department of Cardiology, Zhongshan Hospital Fudan University Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Interventional Medicine Shanghai China"},{"name":"Department of Cardiology, Zhongshan Hospital Fudan University Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9926-5708","authenticated-orcid":false,"given":"Daxin","family":"Zhou","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Interventional Medicine Shanghai China"},{"name":"Department of Cardiology, Zhongshan Hospital Fudan University Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0530-261X","authenticated-orcid":false,"given":"Wenzhi","family":"Pan","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Interventional Medicine Shanghai China"},{"name":"Department of Cardiology, Zhongshan Hospital Fudan University Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8765-4941","authenticated-orcid":false,"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Interventional Medicine Shanghai China"},{"name":"Department of Cardiology, Zhongshan Hospital Fudan University Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,5]]},"reference":[{"issue":"7","key":"e_1_2_10_2_1","first-page":"561","article-title":"ESC\/EACTS guidelines\u00a0for the management of valvular heart disease","volume":"43","author":"Vahanian A","year":"2021","journal-title":"Eur Heart J, 2022"},{"issue":"4","key":"e_1_2_10_3_1","first-page":"450","article-title":"ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"77","author":"Jneid H","year":"2020","journal-title":"J Am Coll Cardiol, 2021"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.21037\/atm-22-2588"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2017.03.004"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-023-03329-1"},{"issue":"3","key":"e_1_2_10_7_1","first-page":"257","article-title":"Self\u2010Expanding transcatheter aortic valve replacement for pure aortic regurgitation with extremely horizontal aorta: a case series","volume":"34","author":"Dai H","year":"2022","journal-title":"J Invasive Cardiol"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.10.069"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.30795"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-18-00935"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-019-01422-0"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2020-318682"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.10.006"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/CP9.0000000000000024"},{"key":"e_1_2_10_15_1","doi-asserted-by":"crossref","unstructured":"VARC\u20103 WRITING COMMITTEE G\u00e9n\u00e9reux\u00a0P \u00a0Piazza\u00a0N et al. Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research.Eur Heart J.\u00a02021;42(19):1825\u20101857.","DOI":"10.1093\/eurheartj\/ehaa799"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.28226"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.26912"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2015.02.005"},{"issue":"11","key":"e_1_2_10_19_1","article-title":"Clinical outcomes and experience of patients with pure aortic regurgitation after transcatheter aortic valve replacement","volume":"31","author":"Zhang LY","year":"2023","journal-title":"Chin J Intervent Cardiol"}],"updated-by":[{"DOI":"10.1002\/ccd.31138","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000}}],"container-title":["Catheterization and Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccd.31064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T06:41:38Z","timestamp":1717396898000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccd.31064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10.1002\/ccd.31064"],"URL":"https:\/\/doi.org\/10.1002\/ccd.31064","archive":["Portico"],"relation":{"erratum":[{"id-type":"doi","id":"10.1002\/ccd.31138","asserted-by":"object"}]},"ISSN":["1522-1946","1522-726X"],"issn-type":[{"value":"1522-1946","type":"print"},{"value":"1522-726X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"2023-12-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}